Rapamycin for Longevity 2022

Rapamycin acts as a potent longevity intervention by modulating the TOR protein, a fundamental regulator of cell growth, inflammation, and autophagy. Research indicates that inhibiting TOR can reverse aging phenotypes, including hair loss, skin collagen degradation, periodontal disease, and reproductive decline in animal models. Beyond these markers, rapamycin demonstrates potential in mitigating chronic age-related conditions such as cardiovascular disease, cancer, and Alzheimer’s. While animal studies consistently show dramatic lifespan extension, human application remains in early stages, necessitating careful medical oversight. The broader field of regenerative medicine, including gene therapy and advanced biological interventions, faces significant regulatory barriers in the United States, prompting calls for increased public advocacy to accelerate access to life-extending technologies. Experts emphasize that while current results are promising, these interventions should complement, rather than replace, foundational lifestyle and dietary health practices.